期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Predicting Hepatocellular Carcinoma Using Brightness Change Curves Derived From Contrast-enhanced Ultrasound Images
1
作者 CHEN Ying-Ying JIANG Shang-Lin +3 位作者 HUANG Liang-Hui ZENG Ya-Guang WANG Xue-Hua ZHENG Wei 《生物化学与生物物理进展》 北大核心 2025年第8期2163-2172,共10页
Objective Primary liver cancer,predominantly hepatocellular carcinoma(HCC),is a significant global health issue,ranking as the sixth most diagnosed cancer and the third leading cause of cancer-related mortality.Accura... Objective Primary liver cancer,predominantly hepatocellular carcinoma(HCC),is a significant global health issue,ranking as the sixth most diagnosed cancer and the third leading cause of cancer-related mortality.Accurate and early diagnosis of HCC is crucial for effective treatment,as HCC and non-HCC malignancies like intrahepatic cholangiocarcinoma(ICC)exhibit different prognoses and treatment responses.Traditional diagnostic methods,including liver biopsy and contrast-enhanced ultrasound(CEUS),face limitations in applicability and objectivity.The primary objective of this study was to develop an advanced,lightweighted classification network capable of distinguishing HCC from other non-HCC malignancies by leveraging the automatic analysis of brightness changes in CEUS images.The ultimate goal was to create a user-friendly and cost-efficient computer-aided diagnostic tool that could assist radiologists in making more accurate and efficient clinical decisions.Methods This retrospective study encompassed a total of 161 patients,comprising 131 diagnosed with HCC and 30 with non-HCC malignancies.To achieve accurate tumor detection,the YOLOX network was employed to identify the region of interest(ROI)on both B-mode ultrasound and CEUS images.A custom-developed algorithm was then utilized to extract brightness change curves from the tumor and adjacent liver parenchyma regions within the CEUS images.These curves provided critical data for the subsequent analysis and classification process.To analyze the extracted brightness change curves and classify the malignancies,we developed and compared several models.These included one-dimensional convolutional neural networks(1D-ResNet,1D-ConvNeXt,and 1D-CNN),as well as traditional machine-learning methods such as support vector machine(SVM),ensemble learning(EL),k-nearest neighbor(KNN),and decision tree(DT).The diagnostic performance of each method in distinguishing HCC from non-HCC malignancies was rigorously evaluated using four key metrics:area under the receiver operating characteristic(AUC),accuracy(ACC),sensitivity(SE),and specificity(SP).Results The evaluation of the machine-learning methods revealed AUC values of 0.70 for SVM,0.56 for ensemble learning,0.63 for KNN,and 0.72 for the decision tree.These results indicated moderate to fair performance in classifying the malignancies based on the brightness change curves.In contrast,the deep learning models demonstrated significantly higher AUCs,with 1D-ResNet achieving an AUC of 0.72,1D-ConvNeXt reaching 0.82,and 1D-CNN obtaining the highest AUC of 0.84.Moreover,under the five-fold cross-validation scheme,the 1D-CNN model outperformed other models in both accuracy and specificity.Specifically,it achieved accuracy improvements of 3.8%to 10.0%and specificity enhancements of 6.6%to 43.3%over competing approaches.The superior performance of the 1D-CNN model highlighted its potential as a powerful tool for accurate classification.Conclusion The 1D-CNN model proved to be the most effective in differentiating HCC from non-HCC malignancies,surpassing both traditional machine-learning methods and other deep learning models.This study successfully developed a user-friendly and cost-efficient computer-aided diagnostic solution that would significantly enhances radiologists’diagnostic capabilities.By improving the accuracy and efficiency of clinical decision-making,this tool has the potential to positively impact patient care and outcomes.Future work may focus on further refining the model and exploring its integration with multimodal ultrasound data to maximize its accuracy and applicability. 展开更多
关键词 computer-aided diagnostic deep learning hepatocellular carcinoma contrast-enhanced ultrasound brightness change curve
在线阅读 下载PDF
MRI特征在BRCA基因突变与非突变型乳腺癌间的差异研究 被引量:3
2
作者 蔺璐奕 王泽洲 +3 位作者 肖勤 胡震 顾雅佳 尤超 《磁共振成像》 CAS CSCD 北大核心 2024年第1期21-27,共7页
目的 探讨临床病理特征和MRI特征在乳腺癌易感基因(breast cancer susceptibility gene, BRCA)基因突变与非突变型乳腺癌患者中的差异。材料与方法 回顾性分析2011年6月至2017年7月在复旦大学附属肿瘤医院确诊手术并经二代测序确定BRCA... 目的 探讨临床病理特征和MRI特征在乳腺癌易感基因(breast cancer susceptibility gene, BRCA)基因突变与非突变型乳腺癌患者中的差异。材料与方法 回顾性分析2011年6月至2017年7月在复旦大学附属肿瘤医院确诊手术并经二代测序确定BRCA基因状态的81名BRCA基因非突变型和76例BRCA基因突变型乳腺癌患者(包括BRCA1基因突变38例,BRCA2基因突变38例)的临床病理资料、活检前MRI扫描图像和预后资料。采用卡方检验、Fisher’s精确检验和多因素logistic回归分析BRCA基因突变型与非突变型、BRCA1突变型和BRCA2突变型乳腺癌之间临床病理特征及MRI特征的差异。结果 在BRCA基因突变组和非突变型乳腺癌之间,组织学类型的分布差异具有统计学意义(P=0.037)。BRCA基因突变乳腺癌组织学类型为浸润性导管癌(invasive ductal carcinoma, IDC)的比例较高,BRCA1基因和BRCA2基因突变乳腺癌中表现为IDC的比例分别为92.11%和94.74%。单因素分析中,BRCA非突变型乳腺癌更多表现为流入(Ⅰ型)或平台型(Ⅱ型)而非廓清型(Ⅲ型)强化曲线(P=0.041)。BRCA1基因突变乳腺癌和BRCA2基因突变乳腺癌患者间肿块型病灶分布差异具有统计学意义(P=0.030),BRCA2基因突变的病灶表现为不规则形的比例较高,占表现为肿块型的BRCA2基因突变病灶的87.10%。纤维腺体组成和BPE特征在BRCA基因突变和非突变乳腺癌之间差异无统计学意义。结论 BRCA基因突变型和非突变型乳腺癌的组织学类型、分子分型和Ki-67指数存在显著差异,MRI中的病灶形态和强化曲线在单因素分析中也与BRCA基因状态有关。 展开更多
关键词 乳腺癌 BRCA基因突变 鉴别 病灶形态特征 强化曲线 磁共振成像
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部